Rhinoorbitocerebral mucormycosis: A case report and literature review

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 13, Issue 12, 2008, Pages

  Martín Moro, Javier González ^a   Calleja, Jose María López Arcas ^a   García, Miguel Burgueño ^a   Carretero, Jose Luis Cebrián ^a   Rodríguez, Julio García ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

AmphotericineB; Diabetes; Extended maxillectomy; Inmunosupression; Ketoacidosis; Mucormycosis; Paranasal sinuses; Rhizopus oryzae

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; DOXYCYCLINE; GLIPIZIDE; METFORMIN; POSACONAZOLE; PREDNISONE; THEOPHYLLINE;

AGED; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; ENDOSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; MAXILLA RESECTION; MORTALITY; MUCORMYCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; REVIEW; RHINOORBITOCEREBRAL MUCORMYCOSIS;

AGED; BRAIN DISEASES; DIABETES COMPLICATIONS; HUMANS; MALE; MUCORMYCOSIS; NOSE DISEASES; ORBITAL DISEASES;

EID: 59949098154     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Paulltauf A. Mycosis mucorina. Virchows Arch 102:543, 1885.
2. Abedi E, Sismanis A, Choi K, Pastore P. Twenty-five years' experience treating cerebro-rhino-orbital mucormycosis. Laryngoscope. 1984 Aug;94(8):1060-2.
3. Abramson E, Wilson D, Arky RA. Rhinocerebral phycomycosis in association with diabetic ketoacidosis. Report of two cases and a review of clinical and experimental experience with amphotericin B therapy. Ann Intern Med. 1967 Apr;66(4):735-42.
4. Chakrabarti A, Panda N, Varma SC, Singh K, Das A, Sharma SC, et al. Craniofacial zygomycosis caused by Apophysomyces elegans. Mycoses. 1997 Dec;40(11-12):419-21.
5. Fairley C, Sullivan TJ, Bartley P, Allworth T, Lewandowski R. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient. Ophthalmology. 2000 Mar;107(3):555-8.
6. Liang KP, Tleyjeh IM, Wilson WR, Roberts GD, Temesgen Z. Rhinoorbitocerebral mucormycosis caused by Apophysomyces elegans. J Clin Microbiol. 2006 Mar;44(3):892-8.
7. Tiong WH, Ismael T, McCann J. Post-traumatic and post-surgical Absidia corymbifera infection in a young, healthy man. J Plast Reconstr Aesthet Surg. 2006;59(12):1367-71.
8. Garcia-Covarrubias L, Bartlett R, Barratt DM, Wassermann RJ. Rhino-orbitocerebral mucormycosis attributable to Apophysomyces elegans in an immunocompetent individual: case report and review of the literature. J Trauma. 2001 Feb;50(2):353-7.
9. Sykes LM, Sukha A. Potential risk of serious oral infections in the diabetic patient: a clinical report. J Prosthet Dent. 2001 Dec;86(6):569-73.
10. Ferry AP, Abedi S. Diagnosis and management of rhino-orbitocerebral mucormycosis (phycomycosis). A report of 16 personally observed cases. Ophthalmology. 1983 Sep;90(9):1096-104.
11. Auluck A. Maxillary necrosis by mucormycosis. a case report and literature review. Med Oral Patol Oral Cir Bucal. 2007 Sep 1;12(5):E360-4.
12. Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005 Jul;18(3):556-69.
13. Ochi JW, Harris JP, Feldman JI, Press GA. Rhinocerebral mucormycosis: results of aggressive surgical debridement and amphotericin B. Laryngoscope. 1988 Dec;98(12):1339-42.
14. Dannaoui E, Meletiadis J, Mouton JW, Meis JF, Verweij PE, Eurofung Network. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother. 2003 Jan;51(1):45-52.
15. Greenberg RN, Mullane K, Van Burik JA, Raad I, Abzug MJ, Anstead G, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother. 2006 Jan;50(1):126-33.